Stress and Anxiety Effects on Valuation

December 19, 2025 updated by: NYU Langone Health
The purpose of this study is to understand how stress, anxiety, and negative affect change learning and decision-making processes. The primary objective is to assess two forms of decision-making-reward adaptation and emotion prediction errors-differ as a function of stress and anxiety. The secondary objectives are to assess how individual differences measured in our studies relate to these decision variables.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • New York, New York, United States, 10016
        • Recruiting
        • NYU Langone Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Aims 1-3: To be eligible for participation in this study, an individual must meet all of the following criteria:

  • 18-65 years of age
  • Able to speak, read, and write fluently in English
  • Be willing and able to follow study procedures and provide informed consent.

Aim 4: To be eligible for participation in this study, an individual must meet all of the following criteria:

  • 18-65 years of age
  • Diagnosis of GAD
  • Able to speak, read, and write fluently in English
  • Be willing and able to follow study procedures and provide informed consent.

Exclusion Criteria:

Aims 1-3: Individuals will be excluded from participation if any of the following criteria are met:

  • History of or medication for neurologic or psychiatric disease
  • High-blood pressure or heart condition
  • Diabetes, food allergies, metabolic disorders or history of eating disorder
  • Use of corticosteroids or beta-blockers
  • Pregnancy

Aim 4: Individuals will be excluded from participation if any of the following criteria are met:

  • High-blood pressure or heart condition
  • Diabetes, food allergies, metabolic disorders or history of eating disorder
  • Use of corticosteroids or beta-blockers
  • Lifetime history of bipolar disorder or any psychotic disorder; substance use disorder in past 3 months; eating disorder in past 6 months; current major depressive disorder (past is allowed)
  • Active suicidal ideation with plan and intent (indicated by score >=4 on the Columbia Suicide Severity Scale)
  • Not on stable dose of psychiatric medication for at least 4 weeks prior to study participation
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aim 3: Socially Evaluated Cold Pressor Task (SECPT)
Participants will first complete demographic and self-report measures, followed by random assignment to complete the SECPT. Cortisol samples will be collected throughout the study session to measure neuroendocrine response to the stress/control task. Participants will then complete the Affective Prediction Error Task.
The SECPT is a validated laboratory stressor that combines physiological stress with social evaluative components; it is widely used to elicit acute stress responses in controlled settings. Participants are asked to submerge their nondominant hand into an ice-cold water (0-4°C) for 3 minutes, while videotaped and observed by one neutral-faced experimenter.
Experimental: Aim 1: Socially Evaluated Cold Pressor Task (SECPT)
Participants will be randomly assigned to complete the Socially Evaluated Cold Pressor Task (SECPT). Cortisol samples will be collected throughout the study session. All participants will then complete a Food Value Task, during which they will view a series of reward stimuli (snack foods) over alternating task blocks.
The SECPT is a validated laboratory stressor that combines physiological stress with social evaluative components; it is widely used to elicit acute stress responses in controlled settings. Participants are asked to submerge their nondominant hand into an ice-cold water (0-4°C) for 3 minutes, while videotaped and observed by one neutral-faced experimenter.
Active Comparator: Aim 1: Non-Stressful Control Task
Participants will be randomly assigned to complete a non-stressful control task. Cortisol samples will be collected throughout the study session. All participants will then complete a Food Value Task, during which they will view a series of reward stimuli (snack foods) over alternating task blocks.
Participants assigned to the warm water control condition will perform a non-evaluative task with warm water.
Experimental: Aim 2: Socially Evaluated Cold Pressor Task (SECPT)
Participants will be randomly assigned to complete the SECPT. Cortisol samples will be collected throughout the study session. Participants will then complete the Image Value Task, during which they will view a series of positive, negative or neutral images over alternating task blocks.
The SECPT is a validated laboratory stressor that combines physiological stress with social evaluative components; it is widely used to elicit acute stress responses in controlled settings. Participants are asked to submerge their nondominant hand into an ice-cold water (0-4°C) for 3 minutes, while videotaped and observed by one neutral-faced experimenter.
Active Comparator: Aim 2: Non-Stressful Control Task
Participants will be randomly assigned to complete a non-stressful control task. Cortisol samples will be collected throughout the study session. Participants will then complete the Image Value Task, during which they will view a series of positive, negative or neutral images over alternating task blocks.
Participants assigned to the warm water control condition will perform a non-evaluative task with warm water.
Active Comparator: Aim 3: Non-Stressful Control Task
Participants will be randomly assigned to complete a non-stressful control task. Cortisol samples will be collected throughout the study session. Participants will then complete the Affective Prediction Task.
Participants assigned to the warm water control condition will perform a non-evaluative task with warm water.
No Intervention: Aim 4: Behavioral Task
Participants with a diagnosis of generalized anxiety disorder (GAD) will complete a two-session behavioral task examining how clinical anxiety affects value and affective predictions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Value Assigned to Food Stimuli
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Measured as participants' willingness-to-pay ($) for snack foods across the behavioral task. (Aims 1 and 4).
Study Visit (Day 1 - Approx. 2 Hours)
Valence Rating Score of OASIS Images
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Valence is rated on a scale from 0 (very negative) to 6 (very positive). (Aims 2 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Pleasantness Rating Score of OASIS Images
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Pleasantness is rated on a scale from 0 (very unpleasant) to 6 (very pleasant). (Aims 2 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Intensity Rating Score of OASIS Images
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Intensity is rated on a scale from 0 (very low) to 6 (very high). (Aims 2 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Emotion Predictions - Valence
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Difference in valence ratings before and after trial outcomes. (Aims 3 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Emotion Predictions - Pleasantness
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Difference in pleasantness ratings before and after trial outcomes. (Aims 3 and 4)
Study Visit (Day 1 - Approx. 2 Hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale (PSS) Score
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
The PSS is a 10-item assessment of stressful feelings and thoughts over the past month; each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (fairly often). The total score is the sum of responses and ranges from 0-20. Higher scores indicate greater levels of perceived stress. (Aims 3 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Holmes-RaHe Life Stress Inventory Score
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
Measurement of lifetime stress; comprises 43 items, each item represents a stressful event that may have occurred over the course of the participant's lifetime. The total score is the total number of stressful events that have occured; the total score ranges from 0-43; higher scores indicate greater lifetime stress. (Aims 3 and 4)
Study Visit (Day 1 - Approx. 2 Hours)
Multidimensional Assessment of Interoceptive Awareness (MAIA-2) Score
Time Frame: Study Visit (Day 1 - Approx. 2 Hours)
The MAIA-2 is a 37-item assessment of interoceptive awareness. Each item is rated on a 6-point Likert scale from 0 (never) to 5 (always); the total score is the average of responses and ranges from 0 to 5; higher scores indicate greater equates to more awareness of bodily sensation.
Study Visit (Day 1 - Approx. 2 Hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Candace Raio, PhD, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2025

Primary Completion (Estimated)

November 7, 2028

Study Completion (Estimated)

November 7, 2028

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Estimated)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 25-01195

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data collected in this study will be used for upcoming grant submissions and not publication. We do not intend to share unpublished pilot data that goes into our grant proposals. The data collected in this study are used to acquire funding for a fully powered version of this pilot study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reward Value Level

Clinical Trials on Socially Evaluated Cold Pressor Task (SECPT)

Subscribe